Sign In  |  Register  |  About Pleasanton  |  Contact Us

Pleasanton, CA
September 01, 2020 1:32pm
7-Day Forecast | Traffic
  • Search Hotels in Pleasanton

  • ROOMS:

2022 R&D Spending and Intensity Benchmarks

By: PRLog

VIRGINIA BEACH, Va. - June 12, 2023 - PRLog -- According to a newly released study from Schonfeld & Associates, Inc., R&D Ratios & Budgets, the pharmaceutical industry continued to be the biggest R&D investor in fiscal 2022 with budgets of drug companies increasing by 8% to $171 billion. Software companies contributed a total of over $200 billion to this investment pool.

The biggest single R&D investor in 2022 was Alphabet at over $39 billion, followed by Meta at $35 billion, and then Microsoft and Apple at over $25 billion each. Firms involved with digital content are investing much more heavily than those in more traditional arenas.

Pharmaceutical firms continued significant R&D spending in 2022. Johnson & Johnson, the top spender at $15.4 billion, is followed by Merck, Pfizer, Novartis, Astrazeneca and Bristol Myers Squibb, each spending over $9 billion. The biotech industry, led by Gilead, grew R&D by just 1% to over $35 billion. Electromedical apparatus makers, led by Medtronic, spent a total of over $3.8 billion, an increase of over ten percent.

R&D budgets of semiconductor makers grew to over $68 billion, an increase of 21.5%. Intel had the largest R&D budget, $17.5 billion, a 15% increase over 2021. R&D budgets of the industries that are major suppliers to the infrastructure of the Internet cloud continue increased R&D spending.

The 2022 R&D spending of the automotive industry, led by General Motors, Toyota, Ford and Honda each spending over $7 billion, was up over 24% from the 2021 total with industry revenues up 38%.

About the Study

R&D Ratios & Budgets
contains fiscal 2021 and 2022 R&D spending, 2022 revenue and 2022 R&D intensity ratio, as well as annual growth rates in R&D spending and sales for over 2,800 firms. Over 280 industry summaries of the same information are provided. The study reports for each company a low and high value for the R&D-to-sales ratio (also known as R&D intensity) for the last five years to indicate stability of R&D spending.

R&D Ratios & Budgets is used for budget planning, monitoring competition, identifying joint venture partners, and spotting acquisition candidates.

The 2023 edition of the PDF report is $ 395 and the report along with Excel datafiles is $ 495. Contact Schonfeld & Associates, Inc., 1932 Terramar Lane, Virginia Beach, VA 23456. Call for more information: 800-205-0030 or visit the company's web site for immediate download at under Area of Expertise: Research & Development Spending.

Carol J. Greenhut

Photos: (Click photo to enlarge)

Schonfeld & Associates, Inc. Logo R&D Intensity By Industry Sector R&D Growth by Country Sample Page R&D Ratios & Budgets

Read Full Story - 2022 R&D Spending and Intensity Benchmarks | More news from this source

Press release distribution by PRLog
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Photography by Christophe Tomatis
Copyright © 2010-2020 & California Media Partners, LLC. All rights reserved.